Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 1
1992 4
1993 1
1994 10
1995 3
1996 4
1997 10
1998 5
1999 10
2000 4
2001 3
2002 8
2003 7
2004 7
2005 11
2006 7
2007 5
2008 4
2009 4
2010 2
2011 1
2012 5
2013 1
2014 4
2015 2
2016 6
2017 4
2018 4
2019 5
2020 4
2021 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
T-cell responses of vaccinated cancer patients.
Coulie PG, van der Bruggen P. Coulie PG, et al. Among authors: van der bruggen p. Curr Opin Immunol. 2003 Apr;15(2):131-7. doi: 10.1016/s0952-7915(03)00009-8. Curr Opin Immunol. 2003. PMID: 12633661 Review.
Human T cell responses against melanoma.
Boon T, Coulie PG, Van den Eynde BJ, van der Bruggen P. Boon T, et al. Among authors: van der bruggen p. Annu Rev Immunol. 2006;24:175-208. doi: 10.1146/annurev.immunol.24.021605.090733. Annu Rev Immunol. 2006. PMID: 16551247 Review.
How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions.
Bruger AM, Dorhoi A, Esendagli G, Barczyk-Kahlert K, van der Bruggen P, Lipoldova M, Perecko T, Santibanez J, Saraiva M, Van Ginderachter JA, Brandau S. Bruger AM, et al. Among authors: van der bruggen p. Cancer Immunol Immunother. 2019 Apr;68(4):631-644. doi: 10.1007/s00262-018-2170-8. Epub 2018 May 21. Cancer Immunol Immunother. 2019. PMID: 29785656 Review.
Tumor antigens recognized by T lymphocytes.
Boon T, Cerottini JC, Van den Eynde B, van der Bruggen P, Van Pel A. Boon T, et al. Among authors: van der bruggen p. Annu Rev Immunol. 1994;12:337-65. doi: 10.1146/annurev.iy.12.040194.002005. Annu Rev Immunol. 1994. PMID: 8011285 Review.
Human tumor antigens recognized by T lymphocytes.
Boon T, van der Bruggen P. Boon T, et al. Among authors: van der bruggen p. J Exp Med. 1996 Mar 1;183(3):725-9. doi: 10.1084/jem.183.3.725. J Exp Med. 1996. PMID: 8642276 Free PMC article. Review. No abstract available.
Genes coding for tumor antigens recognized by cytolytic T lymphocytes.
Van Pel A, van der Bruggen P, Coulie PG, Brichard VG, Lethé B, van den Eynde B, Uyttenhove C, Renauld JC, Boon T. Van Pel A, et al. Among authors: van der bruggen p. Immunol Rev. 1995 Jun;145:229-50. doi: 10.1111/j.1600-065x.1995.tb00084.x. Immunol Rev. 1995. PMID: 7590828 Review. No abstract available.
139 results